1-Methoxy-1-(trimethylsiloxy)-2-methyl-1-propene, 95%, 25g

5-(di-tert-Butylphosphino)-1',3',5'-triphenyl-1'H-1,4'-bipyrazole, 98%, 1g

3-(3-Phenoxyphenyl)propan-1-ol, 95%, 2g

N-(2-Methoxybenzyl)piperidine-4-amine dihydrochloride, 95.0%, 5g

4-[4-(Morpholino)butoxy]benzaldehyde hydrochloride, 95.0%, 5g

Objectif IOS E-plan EPLi S40x/0,65 corrigé à l'infini. Distance de travail 0,78 mm

9-BOC-2-OXO-3-OXA-1,9-DIAZA-SPIRO[5.5]UNDECANE, 95.0%, 100mg

Ethyl 5-(N-Boc)aminomethylisoxazole-3-carboxylate, 97%, 250mg

(R)-1-(4-Bromothiophen-2-yl)ethanol, 98+%, 100mg

1,4-Dibromonaphthalene, 98.0%, 1g

1,4-Dimethoxy-2-(2-nitroprop-1-en-1-yl)benzene, 95% mix TBC as stabilizer, 25g

5-[4-(ethylsulfonyl)phenyl]-1,3,4-oxadiazol-2-amine, 95.0%, 250mg

1-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1,3-DIOXOISOINDOLIN-4-YL)AMINO)-3,6,9,12,15-PENTAOXAOCTADECAN-18-OIC ACID, 95%, 50mg